11. Mannosylated liposomes improve therapeutic effects of paclitaxel in colon cancer models. (18th August 2017) Authors: Xiong, Menghua; Lei, Qian; You, Xinyu; Gao, Tiantao; Song, Xuejiao; Xia, Yong; Ye, Tinghong; Zhang, Lidan; Wang, Ningyu; Yu, Luoting Journal: Journal of microencapsulation Issue: Volume 34:Number 6(2017) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis. (31st March 2019) Authors: Gao, Tiantao; Hu, Quanfang; Hu, Xi; Lei, Qian; Feng, Zhanzhan; Yu, Xi; Peng, Cuiting; Song, Xuejiao; He, Hualong; Xu, Ying; Zuo, Weiqiong; Zeng, Jun; Liu, Zhihao; Yu, Luoting Journal: Cancer letters Issue: Volume 445(2019) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux. (January 2021) Authors: Xia, Yong; Xu, Fuyan; Xiong, Meiping; Yang, Hao; Lin, Wentao; Xie, Yao; Xi, Huizhi; Xue, Qiang; Ye, Tinghong; Yu, Luoting Journal: Pharmacological research Issue: Volume 163(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Selective and efficient synthesis of trans-arylvinylboronates and trans-hetarylvinylboronates using palladium catalyzed cross-coupling. (27th March 2017) Authors: Liu, Zhihao; Wei, Wei; Xiong, Lu; Feng, Qiang; Shi, Yaojie; Wang, Ningyu; Yu, Luoting Journal: New journal of chemistry Issue: Volume 41:Number 8(2017) Page Start: 3172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Synthesis and biological evaluation of (E)-4-(3-arylvinyl-1H-indazol-6-yl)pyrimidin-2-amine derivatives as PLK4 inhibitors for the treatment of breast cancer. Issue 44 (24th May 2017) Authors: Liu, Zhihao; Lei, Qian; Wei, Wei; Xiong, Lu; Shi, Yaojie; Yan, Guoyi; Gao, Chao; Ye, Tinghong; Wang, Ningyu; Yu, Luoting Journal: RSC advances Issue: Volume 7:Issue 44(2017) Page Start: 27737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Synthesis and biological evaluation of indazole derivatives as anti-cancer agents. Issue 26 (27th April 2021) Authors: Wei, Wei; Liu, Zhihao; Wu, Xiuli; Gan, Cailing; Su, Xingping; Liu, Hongyao; Que, Hanyun; Zhang, Qianyu; Xue, Qiang; Yue, Lin; Yu, Luoting; Ye, Tinghong Journal: RSC advances Issue: Volume 11:Issue 26(2021) Page Start: 15675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Synthesis and biological evaluation of N-(4-phenylthiazol-2-yl)cinnamamide derivatives as novel potential anti-tumor agents1. Issue 6 (10th June 2015) Authors: Luo, Yong; Zhu, Yongxia; Ran, Kai; Liu, Zhihao; Wang, Ningyu; Feng, Qiang; Zeng, Jun; Zhang, Lidan; He, Bing; Ye, Tinghong; Zhu, Shirui; Qiu, Xiaolong; Yu, Luoting Journal: MedChemComm Issue: Volume 6:Issue 6(2015:Jun.) Page Start: 1036 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. The discovery of SKLB-0335 as a paralog-selective EZH2 covalent inhibitor. Issue 24 (24th February 2021) Authors: Zhang, Qiangsheng; Hu, Xi; Li, Lu; Zhang, Lidan; Wan, Guoquan; Feng, Qiang; Zhu, Yongxia; Wang, Ningyu; Liu, Zhihao; Yu, Luoting Journal: Chemical communications Issue: Volume 57:Issue 24(2021) Page Start: 3006 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis. (June 2022) Authors: Gou, Zongchao; Lu, Xunxi; He, Mengting; Yu, Luoting Journal: Breast Issue: Volume 63(2022) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumour growth in preclinical models. (26th July 2013) Authors: Xu, Youzhi; Lin, Hongjun; Meng, Nana; Lu, Wenjie; Li, Guobo; Han, Yuanyuan; Dai, Xiaoyun; Xia, Yong; Song, Xiangrong; Yang, Shengyong; Wei, Yuquan; Yu, Luoting; Zhao, Yinglan Journal: British journal of pharmacology Issue: Volume 169:Number 8(2013:Aug.) Page Start: 1766 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗